Modified Aerotaxy for the Plug-in Manufacture of Cell-Penetrating Fenton Nanoagents for Reinforcing Chemodynamic Cancer Therapy

被引:6
|
作者
Poudel, Kishwor [1 ,2 ]
Nam, Kang Sik [3 ]
Lim, Jiseok [5 ]
Ku, Sae Kwang [4 ]
Hwang, Jungho [3 ]
Kim, Jong Oh [1 ]
Byeon, Jeong Hoon [5 ]
机构
[1] Yeungnam Univ, Coll Pharm, Gyongsan 38541, South Korea
[2] Meassachusetts Gen Hosp, Wellman Ctr Photomed, Harvard Med Sch, Dept Dermatol, Boston, MA 02114 USA
[3] Yonsei Univ, Sch Mech Engn, Seoul 03722, South Korea
[4] Daegu Haany Univ, Coll Korean Med, Gyongsan 38610, South Korea
[5] Yeungnam Univ, Sch Mech Engn, Gyongsan 38541, South Korea
基金
新加坡国家研究基金会;
关键词
anisotropic nanomaterials; modified aerotaxy; Fenton nanoagents; cellular internalization; chemo-immuno-chemodynamic combination therapeutics; MESOPOROUS SILICA NANOPARTICLES; MNFE2O4; NANOPARTICLES; FACILE SYNTHESIS; COMBINATION; DOXORUBICIN; DEPOSITION; RESISTANCE; MORPHOLOGY; EXPRESSION; NANOWIRES;
D O I
10.1021/acsnano.2c09136
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The assemblies of anisotropic nanomaterials have attracted considerable interest in advanced tumor therapeutics because of the extended surfaces for loading of active molecules and the extraordinary responses to external stimuli for combinatorial therapies. These nanomaterials were usually constructed through templated or seed-mediated hydrothermal reactions, but the lack of uniformity in size and morphology, as well as the process complexities from multiple separation and purification steps, impede their practical use in cancer nanotherapy. Gas-phase epitaxy, also called aerotaxy (AT), has been introduced as an innovative method for the continuous assembly of anisotropic nanomaterials with a uniform distribution. This process does not require expensive crystal substrates and high vacuum conditions. Nevertheless, AT has been used limitedly to build high-aspect-ratio semiconductor nanomaterials. With these considerations, a modified AT was designed for the continuous in-flight assembly of the cell-penetrating Fenton nanoagents (Mn-Fe CaCO3 (AT) and Mn-Fe SiO2 (AT)) in a single-pass gas flow because cellular internalization activity is essential for cancer nanotherapeutics. The modified AT of Mn-Fe CaCO3 and Mn-Fe SiO2 to generate surface nanoroughness significantly enhanced the cellular internalization capability because of the preferential contact mode with the cancer cell membrane for Fenton reaction-induced apoptosis. In addition, it was even workable for doxorubicin (DOX)-resistant cancer cells after DOX loading on the nanoagents. After combining with immune-checkpoint blockers (antiprogrammed death-ligand 1 antibodies), the antitumor effect was improved further with no systemic toxicity as chemo-immuno-chemodynamic combination therapeutics despite the absence of targeting ligands and external stimuli.
引用
收藏
页码:19423 / 19438
页数:16
相关论文
共 36 条
  • [1] Disruptin, a cell-penetrating peptide degrader of EGFR Cell-Penetrating Peptide in Cancer Therapy
    Mehta, Ranjit K.
    Shukla, Sushmita
    Ramanand, Susmita G.
    Somnay, Vishal
    Bridges, Alexander J.
    Lawrence, Theodore S.
    Nyati, Mukesh K.
    TRANSLATIONAL ONCOLOGY, 2021, 14 (08):
  • [2] The Current Role of Cell-Penetrating Peptides in Cancer Therapy
    Feni, Lucia
    Neundorf, Ines
    PEPTIDES AND PEPTIDE-BASED BIOMATERIALS AND THEIR BIOMEDICAL APPLICATIONS, 2017, 1030 : 279 - 295
  • [3] Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging
    Wang, Weiqin
    Abbad, Sarra
    Zhang, Zhenhai
    Wang, Shu
    Zhou, Jianping
    Lv, Huixia
    CURRENT CANCER DRUG TARGETS, 2015, 15 (04) : 337 - 351
  • [4] Nanoparticles Modified with Cell-Penetrating Peptides: Conjugation Mechanisms, Physicochemical Properties, and Application in Cancer Diagnosis and Therapy
    Gessner, Isabel
    Neundorf, Ines
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (07)
  • [5] The role of cell-penetrating peptides in potential anti-cancer therapy
    Zhou, Meiling
    Zou, Xi
    Cheng, Kexin
    Zhong, Suye
    Su, Yangzhou
    Wu, Tao
    Tao, Yongguang
    Cong, Li
    Yan, Bin
    Jiang, Yiqun
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (05):
  • [6] Cell-penetrating chitosan/doxorubicin/TAT conjugates for efficient cancer therapy
    Lee, Jue-Yeon
    Choi, Young-Suk
    Suh, Jin-Sook
    Kwon, Young-Min
    Yang, Victor C.
    Lee, Seung-Jin
    Chung, Chong-Pyoung
    Park, Yoon-Jeong
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (10) : 2470 - 2480
  • [7] Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma
    Wang, Xi
    Zhao, Yarong
    Dong, Shiyan
    Lee, Robert J.
    Yang, Dongsheng
    Zhang, Huan
    Teng, Lesheng
    MOLECULES, 2022, 27 (17):
  • [8] Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma
    Wang, Xi
    Zhao, Yarong
    Dong, Shiyan
    Lee, Robert J.
    Yang, Dongsheng
    Zhang, Huan
    Teng, Lesheng
    MOLECULES, 2019, 24 (19):
  • [9] Increasing the potential of cell-penetrating peptides for cancer therapy using a new pentagonal scaffold
    Duarte, Diana
    Fraga, Alexandra G.
    Pedrosa, Jorge
    Martel, Fatima
    Vale, Nuno
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 860
  • [10] Engineered Cell-Penetrating Peptides for Mitochondrion-Targeted Drug Delivery in Cancer Therapy
    Xiao, Qicai
    Dong, Xiao
    Yang, Fen
    Zhou, Shizhe
    Xiang, Menghua
    Lou, Liang
    Yao, Shao Q.
    Gao, Liqian
    CHEMISTRY-A EUROPEAN JOURNAL, 2021, 27 (59) : 14721 - 14729